Medicare will start the GLP-1 Bridge program July 1. Older adults who qualify for the weight-loss drugs will pay a monthly ...
A new Medicare GLP-1 Bridge program offers Wegovy and Zepbound to eligible seniors for $50 a month starting July 1, slashing ...
The share of U.S. adults taking GLP-1 medications to lose weight has reached a record 11%. That's about 40 million people—as ...
Millions of Medicare enrollees will gain their first-ever coverage for drugs for weight loss under a temporary pilot program ...
For the first time ever, Medicare will cover drugs like Wegovy and Zepbound. But a strict BMI checklist and a 2027 deadline ...
Millions of Americans are expected to gain coverage for GLP-1 drugs for weight loss under a new U.S. pilot launching on ...
Starting this week, the federal government is offering a selection of the brand name medications to certain Medicare and Medicare Advantage beneficiaries for $50 a month through a new trial called ...
The Trump administration will launch its pilot program on Wednesday. It lasts 18 months, and estimated costs to taxpayers ...
GoodRx reports that Medicare's new GLP-1 Bridge program allows eligible Part D enrollees to access weight-loss medications ...
Medicare previously covered GLP-1s only if the beneficiary also had a condition such as diabetes, sleep apnea, high blood ...
To achieve weight loss, consistent effort is vital. A nutritionist offers a seven-point strategy, including reducing calories ...
For the first time, Medicare will cover GLP-1 drugs prescribed solely for weight loss for eligible beneficiaries at a $50 ...